Hamlet BioPharma Featured on "The Bio Report" Biotech Podcast
Hamlet BioPharma's chairman, Professor Catharina Svanborg, was interviewed on "The Bio Report" podcast. The discussion covered the company's therapies for non-muscle invasive bladder cancer and its clinical trials.
Hamlet BioPharma was featured on "The Bio Report," a podcast focused on the biotechnology sector. Professor Catharina Svanborg, Chairman of Hamlet BioPharma, participated in an interview discussing the company's new class of therapies for non-muscle invasive bladder cancer.
The "The Bio Report" podcast, hosted by journalist Daniel Levine, explores the intersection of disease with business, science, and policy. It features interviews with leaders in the pharmaceutical, biotech, and health industries.
The interview addressed Hamlet BioPharma's ongoing clinical trials, future innovation strategies, and expansion plans. Cision News provided the information about the company's participation in the podcast.